Table 1.
Characteristics of participants at baselinea.
| Quartile | ||||||
|---|---|---|---|---|---|---|
| Nb | Median | First | Third | Min | Max | |
| Age (y) | 224 | 54.33 | 52.06 | 56.79 | 45.84 | 65.04 |
| TLMPc (y) | 224 | 2.76 | 1.76 | 5.02 | 0.79 | 10.02 |
| Family History of CVD (n) | 224 | |||||
| No | 88 | |||||
| Yes | 127 | |||||
| Don't know | 9 | |||||
| Weight (kg) | 224 | 66.35 | 59.98 | 73.70 | 43.70 | 93.10 |
| BMI (kg/m2) | 224 | 24.46 | 22.33 | 27.03 | 17.84 | 31.66 |
| Whole body fat massd (%) | 224 | 34.4 | 30.45 | 38.36 | 18.12 | 45.95 |
| Androidal fat massd (kg) | 224 | 5.31 | 4.19 | 7.12 | 1.12 | 10.7 |
| Serum total cholesterol (mg/dL) | 224 | 206.5 | 189 | 226.2 | 142 | 297 |
| Serum LDL-C (mg/dL) | 224 | 127.5 | 109 | 141.2 | 62 | 192 |
| Serum HDL-C (mg/dL) | 224 | 64 | 55.75 | 76 | 30 | 111 |
| Serum triacylglycerol (mg/dL) | 224 | 76 | 59 | 98.25 | 18 | 290 |
| Serum C-reactive protein (mg/L) | 218 | 1.022 | 0.453 | 2.089 | 0.013 | 29.860 |
| Plasma fibrinogen (mg/mL) | 218 | 3.353 | 2.657 | 4.311 | 0.914 | 6.854 |
| Plasma total homocysteine (μmol/L) | 218 | 7.296 | 6.318 | 7.677 | 4.224 | 17.64 |
| RBC folate (ng/mL) | 217 | 10.45 | 8.896 | 12.82 | 4.595 | 40.13 |
| Blood glucose (mg/dL) | 224 | 85 | 80.75 | 90 | 57 | 117 |
| Serum insulin (μU/mL) | 218 | 11.39 | 8.437 | 13.96 | 0.104 | 36.14 |
| HOMAe | 218 | 2.362 | 1.694 | 3.006 | 0.022 | 9.458 |
| Serum uric acid (mg/dL) | 224 | 4.15 | 3.5 | 4.8 | 1.3 | 9 |
| Systolic BP (mm/Hg) | 224 | 119.5 | 112.8 | 132 | 93 | 170 |
| Diastolic BP (mm/Hg) | 224 | 74.5 | 68 | 80 | 49 | 111 |
| Resting heart rate (bpm) | 224 | 68 | 63 | 74 | 44 | 99 |
| Healthy Eating Index score | 224 | 67 | 56 | 76 | 37 | 95 |
aBaseline data are reported for the entire sample. Treatment groups did not differ significantly in any of the outcomes at baseline.
bThe number of observations available at baseline.
cTime since last menstrual period.
dAssessed using dual-energy X-ray absorptiometery (DXA).
eHomeostatic model of insulin resistance.